UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000047446 |
|---|---|
| Receipt number | R000054106 |
| Scientific Title | Investigation of survival factors for cancer patients using data science methods |
| Date of disclosure of the study information | 2022/04/09 |
| Last modified on | 2023/10/10 14:20:37 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Investigation of survival factors for cancer patients using data science methods
Acronym
Investigation of survival factors for cancer patients using data science methods
Scientific Title
Investigation of survival factors for cancer patients using data science methods
Scientific Title:Acronym
Investigation of survival factors for cancer patients using data science methods
Region
| Japan |
Condition
Condition
malignant tumors
Classification by specialty
| Medicine in general | Hematology and clinical oncology | Adult |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Investigating factors associated with long-term survival in long-term cancer survivor patients
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Analyzing survival factors from medical and lifestyle information of long-term cancer survivors.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1) Long-term cancer survivor group: A group of cancer patients who meet the following a) or b)
a) Cancer patients with a 5-year survival rate of 25% or less who survive beyond this statistic. Specifically, if the n-year survival rate is 25% or less, the patient have survived for at least n years.
b) Patients who did not achieve remission with standard treatment, but achieved remission with the alternative medicine.
2) Cancer patient groups other than long-term cancer survivors: Cancer patient groups other than 1)
3) Non-cancer patients: Patients with no cancer diagnosis other than 1) and 2) above.
Key exclusion criteria
If consent to participate in this study cannot be obtained, the patient will be excluded from this study.
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Hiromi |
| Middle name | |
| Last name | Wada |
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Division name
Japanese Society on Inflammation and Metabolism in Cancer, working group
Zip code
604-0842
Address
119 Nishioshikouji-cho, Nakagyo-ku, Kyoto 604-0842, Japan.
TEL
075-223-1100
wadah@kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | Reo |
| Middle name | |
| Last name | Hamaguchi |
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Division name
Japanese Society on Inflammation and Metabolism in Cancer, working group
Zip code
604-0842
Address
119 Nishioshikouji-cho, Nakagyo-ku, Kyoto 604-0842, Japan
TEL
075-223-1100
Homepage URL
reo-h@nifty.com
Sponsor or person
Institute
Japanese Society on Inflammation and Metabolism in Cancer
Institute
Department
Personal name
Funding Source
Organization
Japanese Society on Inflammation and Metabolism in Cancer
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
The Japan-Multinational Trial Organization
Address
2-14-10-3F Marunouchi, Naka-ku, Nagoya, Aichi, Japan
Tel
052-218-3301
info@jmto.org
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 04 | Month | 09 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2016 | Year | 06 | Month | 08 | Day |
Date of IRB
| 2016 | Year | 07 | Month | 25 | Day |
Anticipated trial start date
| 2016 | Year | 07 | Month | 25 | Day |
Last follow-up date
| 2026 | Year | 07 | Month | 24 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Data will be obtained retrospectively on long-term cancer survivors and survival factors will be analyzed.
Management information
Registered date
| 2022 | Year | 04 | Month | 09 | Day |
Last modified on
| 2023 | Year | 10 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054106
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
